TNF-inhibitors have several different safety issues than rituximab, tocilizumab and anakinra, and these distinctions may be important for certain RA patients. The risk/benefit ratio for the ...

Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.

Since IL-6R inhibition has a distinct mechanism of action, some patients who do not respond to antitumor necrosis ... novel IL-6R inhibitor, may be beneficial for the treatment of RA in patients ...